Literature DB >> 19033672

Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans.

Carmela De Santo1, Mariolina Salio, S Hajar Masri, Laurel Yong-Hwa Lee, Tao Dong, Anneliese O Speak, Stefan Porubsky, Sarah Booth, Natacha Veerapen, Gurdyal S Besra, Hermann-Josef Gröne, Frances M Platt, Maria Zambon, Vincenzo Cerundolo.   

Abstract

Infection with influenza A virus (IAV) presents a substantial threat to public health worldwide, with young, elderly, and immunodeficient individuals being particularly susceptible. Inflammatory responses play an important role in the fatal outcome of IAV infection, but the mechanism remains unclear. We demonstrate here that the absence of invariant NKT (iNKT) cells in mice during IAV infection resulted in the expansion of myeloid-derived suppressor cells (MDSCs), which suppressed IAV-specific immune responses through the expression of both arginase and NOS, resulting in high IAV titer and increased mortality. Adoptive transfer of iNKT cells abolished the suppressive activity of MDSCs, restored IAV-specific immune responses, reduced IAV titer, and increased survival rate. The crosstalk between iNKT and MDSCs was CD1d- and CD40-dependent. Furthermore, IAV infection and exposure to TLR agonists relieved the suppressive activity of MDSCs. Finally, we extended these results to humans by demonstrating the presence of myeloid cells with suppressive activity in the PBLs of individuals infected with IAV and showed that their suppressive activity is substantially reduced by iNKT cell activation. These findings identify what we believe to be a novel immunomodulatory role of iNKT cells, which we suggest could be harnessed to abolish the immunosuppressive activity of MDSCs during IAV infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19033672      PMCID: PMC2582442          DOI: 10.1172/JCI36264

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  80 in total

Review 1.  Innate recognition of viruses.

Authors:  Andreas Pichlmair; Caetano Reis e Sousa
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

2.  Role of immunoproteasomes in cross-presentation.

Authors:  Michael J Palmowski; Uzi Gileadi; Mariolina Salio; Awen Gallimore; Maggie Millrain; Edward James; Caroline Addey; Diane Scott; Julian Dyson; Elizabeth Simpson; Vincenzo Cerundolo
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

3.  Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection.

Authors:  K Kawakami; Y Kinjo; K Uezu; S Yara; K Miyagi; Y Koguchi; T Nakayama; M Taniguchi; A Saito
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

4.  A role for natural killer T cells and CD1d molecules in counteracting suppression of hematopoiesis in mice induced by infection with murine cytomegalovirus.

Authors:  Hal E Broxmeyer; Alexander Dent; Scott Cooper; Giao Hangoc; Zheng-Yu Wang; Wenjun Du; Jacquelyn Gervay-Haque; Venkataraman Sriram; Gourapura J Renukaradhya; Randy R Brutkiewicz
Journal:  Exp Hematol       Date:  2007-04       Impact factor: 3.084

5.  Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.

Authors:  Kazuhiko Yanagisawa; Mark A Exley; Xiaofeng Jiang; Nobuhiro Ohkochi; Masaru Taniguchi; Ken-ichiro Seino
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

6.  Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.

Authors:  K Sango; M P McDonald; J N Crawley; M L Mack; C J Tifft; E Skop; C M Starr; A Hoffmann; K Sandhoff; K Suzuki; R L Proia
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

Review 7.  Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

Authors:  Hua Yu; Marcin Kortylewski; Drew Pardoll
Journal:  Nat Rev Immunol       Date:  2007-01       Impact factor: 53.106

8.  Inhibition of CD1d1-mediated antigen presentation by the vaccinia virus B1R and H5R molecules.

Authors:  Tonya J Roberts Webb; Roberta A Litavecz; Masood A Khan; Wenjun Du; Jacquelyn Gervay-Hague; Gourapura J Renukaradhya; Randy R Brutkiewicz
Journal:  Eur J Immunol       Date:  2006-10       Impact factor: 5.532

9.  Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism.

Authors:  Jens Schümann; Federica Facciotti; Luigi Panza; Mario Michieletti; Federica Compostella; Anthony Collmann; Lucia Mori; Gennaro De Libero
Journal:  Eur J Immunol       Date:  2007-06       Impact factor: 5.532

10.  N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.

Authors:  F M Platt; G R Neises; R A Dwek; T D Butters
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

View more
  168 in total

1.  Slam haplotypes modulate the response to lipopolysaccharide in vivo through control of NKT cell number and function.

Authors:  Idil Aktan; Alan Chant; Zachary D Borg; David E Damby; Paige C Leenstra; Graham W J Lilley; Graham W G Lilley; Joseph Petty; Benjamin T Suratt; Cory Teuscher; Edward K Wakeland; Matthew E Poynter; Jonathan E Boyson
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

Review 2.  Immunology in the Clinic Review Series; focus on host responses: invariant natural killer T cell activation following transplantation.

Authors:  J-P Jukes; N D Jones
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

3.  Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Authors:  Christophe Paget; Stoyan Ivanov; Josette Fontaine; Joelle Renneson; Fany Blanc; Muriel Pichavant; Laure Dumoutier; Bernhard Ryffel; Jean Christophe Renauld; Philippe Gosset; Pierre Gosset; Mustapha Si-Tahar; Christelle Faveeuw; François Trottein
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

4.  Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.

Authors:  Markus Moll; Sofia K Andersson; Anna Smed-Sörensen; Johan K Sandberg
Journal:  Blood       Date:  2010-06-08       Impact factor: 22.113

5.  Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.

Authors:  Bo Pei; Anneliese O Speak; Dawn Shepherd; Terry Butters; Vincenzo Cerundolo; Frances M Platt; Mitchell Kronenberg
Journal:  J Immunol       Date:  2010-12-29       Impact factor: 5.422

6.  Lysosomal alpha-galactosidase controls the generation of self lipid antigens for natural killer T cells.

Authors:  Alexandre Darmoise; Susann Teneberg; Lauriane Bouzonville; Roscoe O Brady; Michael Beck; Stefan H E Kaufmann; Florian Winau
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

7.  In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site.

Authors:  Jessica M Haverkamp; Scott A Crist; Bennett D Elzey; Cansu Cimen; Timothy L Ratliff
Journal:  Eur J Immunol       Date:  2011-02-02       Impact factor: 5.532

Review 8.  NKT cell immune responses to viral infection.

Authors:  Marlowe S Tessmer; Ayesha Fatima; Christophe Paget; Francois Trottein; Laurent Brossay
Journal:  Expert Opin Ther Targets       Date:  2009-02       Impact factor: 6.902

9.  Human cytomegalovirus (HCMV) US2 protein interacts with human CD1d (hCD1d) and down-regulates invariant NKT (iNKT) cell activity.

Authors:  Jihye Han; Seung Bae Rho; Jae Yeon Lee; Joonbeom Bae; Se Ho Park; Suk Jun Lee; Sang Yeol Lee; Curie Ahn; Jae Young Kim; Taehoon Chun
Journal:  Mol Cells       Date:  2013-11-08       Impact factor: 5.034

10.  Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes.

Authors:  Lisa P Daley-Bauer; Grace M Wynn; Edward S Mocarski
Journal:  Immunity       Date:  2012-07-27       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.